+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

RNA Interference Technology Market by Molecule Type, Route Of Administration, Delivery Method, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968963
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The RNA Interference Technology Market is experiencing significant evolution, driven by advances in delivery systems, new applications, and a dynamic regulatory environment. As organizations explore next-generation therapies and research capabilities, RNA interference technology is repositioning the competitive landscape globally across diverse end-users and therapeutic areas.

Market Snapshot: RNA Interference Technology Market

In 2024, the RNA Interference Technology Market was valued at USD 2.63 billion and is projected to reach USD 2.95 billion in 2025, with a compound annual growth rate (CAGR) of 12.76%. By 2030, it is anticipated to reach USD 5.42 billion. This robust growth is propelled by accelerated adoption in therapeutic and research settings, continuous delivery innovations, and a steadily expanding global footprint in both developed and emerging regions.

Scope & Segmentation of the RNA Interference Technology Market

This report delivers comprehensive coverage across technology types, applications, regions, and end-user groups. The segmentation delivers actionable insights for strategic decision-making:

  • Molecule Types: MicroRNA, Short Hairpin RNA (shRNA) via both viral and non-viral delivery systems, and Small Interfering RNA (siRNA) through conjugated and non-conjugated forms.
  • Routes of Administration: Intramuscular injections, intrathecal approaches, and intravenous administration.
  • Delivery Methods: Direct naked RNAi, exosome-based therapies, nanoparticle-based carriers, and viral vector-based mechanisms.
  • Applications: Drug discovery (such as lead optimization and target identification), research and development (including gene function studies and pathway analysis), and therapeutic interventions.
  • End-Users: Contract research organizations, hospitals and clinics, pharmaceutical companies, and biotechnology firms.
  • Regions Covered: Americas (notably United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, and South Africa, among others), and Asia-Pacific (with focus on China, India, Japan, Australia, and Southeast Asian countries).
  • Key Companies: Alnylam Pharmaceuticals, AMSBIO, Arbutus Biopharma, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Ionis Pharmaceuticals, Merck KGaA, Novartis AG, Sanofi S.A., Silence Therapeutics, Thermo Fisher Scientific, Vir Biotechnology, and others.

Key Takeaways for Senior Decision-Makers

  • Delivery system innovation, including nanoparticles and exosome-based approaches, is redefining RNAi therapy feasibility for hard-to-treat diseases.
  • Collaborations between established biopharma and emerging RNAi specialists accelerate clinical pipeline development and market readiness.
  • Strategic alliances and technology licensing enable faster adaptation to regulatory changes and emerging therapeutic opportunities.
  • Expansion in regional R&D hubs and public-private partnerships supports increasing technology adoption in both mature and developing markets.
  • Segment performance indicates growing interest in rare disease and oncology, with research and discovery applications laying the groundwork for broader clinical use.
  • Operational resilience is becoming a competitive differentiator, with diversified supply chains and flexible manufacturing approaches mitigating market disruptions.

Tariff Impact: 2025 United States Trade Measures in RNAi

Recent tariffs by the United States government on select raw materials and formulation components have created cost pressures for both research and commercial entities. Global suppliers, especially in Asia and Europe, have responded with price adjustments, while domestic producers seek to expand capacity. These dynamics heighten supply chain complexity and prompt organizations to re-examine their procurement, inventory management, and sourcing strategies. Entities with diversified supplier networks or vertically integrated capabilities are better positioned to maintain stability and competitive margins.

Methodology & Data Sources

Insights were generated using secondary research from scientific journals, patent databases, and regulatory filings, complemented by structured consultations with industry thought leaders, senior executives, and technical experts. Data validation involved triangulation across proprietary databases and industry benchmarks, ensuring a comprehensive and reliable analysis of the RNA Interference Technology Market.

Why This Report Matters

  • Enables executives to align investment, portfolio, and supply chain strategies with the latest technology and regulatory trends in RNA interference.
  • Provides segmentation-driven insights to support market entry, partnership, and geographic expansion decisions across therapeutic and research segments.
  • Equips stakeholders with actionable recommendations to navigate evolving trade policies and technology adoption dynamics.

Conclusion

The RNA Interference Technology Market is reshaping the biopharma landscape, offering breakthrough research and therapeutic possibilities. Stakeholders prepared to navigate regulatory, supply chain, and technological developments are positioned for long-term success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of GalNAc-conjugated siRNA therapeutics for targeted liver disease treatment
5.2. Expansion of lipid nanoparticle delivery platforms to improve systemic distribution of RNAi drugs
5.3. Emergence of RNAi-based combination therapies to overcome resistance mechanisms in oncology treatments
5.4. Advances in AI-driven sequence optimization for enhanced siRNA potency and minimized off-target effects
5.5. Regulatory approvals of novel RNAi therapeutics fueling investment in rare genetic disorder applications
5.6. Strategic partnerships between biopharma firms and academia to innovate RNAi delivery technologies
5.7. Integration of CRISPR screening with RNAi libraries to accelerate target validation in neurodegenerative disease research
5.8. Development of sustainable manufacturing processes for large-scale production of RNA interference constructs
5.9. Exploration of inhalable RNAi formulations for localized pulmonary disease management and delivery
5.10. Growing focus on precision delivery platforms for tissue-specific RNAi therapeutics in cardiovascular diseases
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. RNA Interference Technology Market, by Molecule Type
8.1. Introduction
8.2. MicroRNA (miRNA)
8.3. Short Hairpin RNA (shRNA)
8.3.1. Non-Viral Delivery shRNA
8.3.2. Viral Delivery shRNA
8.4. Small Interfering RNA (siRNA)
8.4.1. Conjugated siRNA
8.4.2. Non-Conjugated siRNA
9. RNA Interference Technology Market, by Route Of Administration
9.1. Introduction
9.2. Intramuscular (IM) Injection
9.3. Intrathecal (IT) Administration
9.4. Intravenous (IV) Injection
10. RNA Interference Technology Market, by Delivery Method
10.1. Introduction
10.2. Direct Naked RNAi Delivery
10.3. Exosome-Based RNAi Therapy
10.4. Nanoparticle-Based Delivery
10.5. Viral Vector-Based Delivery
11. RNA Interference Technology Market, by Application
11.1. Introduction
11.2. Drug Discovery
11.2.1. Lead Optimization
11.2.2. Target Identification
11.3. Research & Development
11.3.1. Gene Function Studies
11.3.2. Pathway Analysis
11.4. Therapeutics
12. RNA Interference Technology Market, by End-User
12.1. Introduction
12.2. Contract Research Organizations
12.3. Hospitals & Clinics
12.4. Pharmaceutical & Biotechnology Companies
13. Americas RNA Interference Technology Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa RNA Interference Technology Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific RNA Interference Technology Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Alnylam Pharmaceuticals, Inc.
16.3.2. AMSBIO
16.3.3. Arbutus Biopharma Corporation
16.3.4. Arcturus Therapeutics Holdings Inc.
16.3.5. Arrowhead Pharmaceuticals, Inc.
16.3.6. Atalanta Therapeutics
16.3.7. Bioneer Corporation
16.3.8. Dicerna Pharmaceuticals, Inc.
16.3.9. Gradalis, Inc.
16.3.10. Horizon Therapeutics plc
16.3.11. Ionis Pharmaceuticals, Inc.
16.3.12. Merck KGaA
16.3.13. Novartis AG
16.3.14. Nutcracker Therapeutics, Inc.
16.3.15. Phio Pharmaceuticals Corp.
16.3.16. ProQR Therapeutics N.V.
16.3.17. Sanofi S.A.
16.3.18. Silence Therapeutics PLC
16.3.19. Sirnaomics, Inc.
16.3.20. Thermo Fisher Scientific Inc.
16.3.21. Vir Biotechnology, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RNA INTERFERENCE TECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RNA INTERFERENCE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RNA INTERFERENCE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RNA INTERFERENCE TECHNOLOGY MARKET: RESEARCHAI
FIGURE 26. RNA INTERFERENCE TECHNOLOGY MARKET: RESEARCHSTATISTICS
FIGURE 27. RNA INTERFERENCE TECHNOLOGY MARKET: RESEARCHCONTACTS
FIGURE 28. RNA INTERFERENCE TECHNOLOGY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RNA INTERFERENCE TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MICRORNA (MIRNA), BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MICRORNA (MIRNA), BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NON-VIRAL DELIVERY SHRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NON-VIRAL DELIVERY SHRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY VIRAL DELIVERY SHRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY VIRAL DELIVERY SHRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY CONJUGATED SIRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY CONJUGATED SIRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NON-CONJUGATED SIRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NON-CONJUGATED SIRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRAMUSCULAR (IM) INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRAMUSCULAR (IM) INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRATHECAL (IT) ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRATHECAL (IT) ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRAVENOUS (IV) INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRAVENOUS (IV) INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DIRECT NAKED RNAI DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DIRECT NAKED RNAI DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY EXOSOME-BASED RNAI THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY EXOSOME-BASED RNAI THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NANOPARTICLE-BASED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NANOPARTICLE-BASED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY VIRAL VECTOR-BASED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY VIRAL VECTOR-BASED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY GENE FUNCTION STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY GENE FUNCTION STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY PATHWAY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY PATHWAY ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 78. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 79. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 80. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 81. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 116. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 117. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 118. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 119. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 120. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 121. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 124. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 125. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 128. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 129. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 130. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 131. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 136. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 137. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 138. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 139. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 142. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 143. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 146. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 147. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 148. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 149. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 154. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 155. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 156. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 157. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 225. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 226. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 227. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 228. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 229. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 230. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 231. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 234. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 235. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 238. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 239. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 240. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 241. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 242. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 243. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 244. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 245. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 246. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 247. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 248. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 249. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 252. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 253. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 256. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 257. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 258. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 259. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 260. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 264. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 265. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 266. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 267. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 279. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 280. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 281. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2024 (USD MILLION)
TABLE 282. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2025-2030 (USD MILLION)
TABLE 283. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2024 (USD MILLION)
TABLE 284. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2025-2030 (USD MILLION)
TABLE 285. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 288. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 289. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 292. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 293. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 294. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 295. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 296. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 297. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 298. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

  • Alnylam Pharmaceuticals, Inc.
  • AMSBIO
  • Arbutus Biopharma Corporation
  • Arcturus Therapeutics Holdings Inc.
  • Arrowhead Pharmaceuticals, Inc.
  • Atalanta Therapeutics
  • Bioneer Corporation
  • Dicerna Pharmaceuticals, Inc.
  • Gradalis, Inc.
  • Horizon Therapeutics plc
  • Ionis Pharmaceuticals, Inc.
  • Merck KGaA
  • Novartis AG
  • Nutcracker Therapeutics, Inc.
  • Phio Pharmaceuticals Corp.
  • ProQR Therapeutics N.V.
  • Sanofi S.A.
  • Silence Therapeutics PLC
  • Sirnaomics, Inc.
  • Thermo Fisher Scientific Inc.
  • Vir Biotechnology, Inc.

Table Information